Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Cash from Investing Activities (2010 - 2025)

Pluri (PLUR) posted quarterly Cash from Investing Activities of $2.7 million for Q4 2025, down 69.25% year-over-year from $8.6 million in Q4 2024, and down 30.96% quarter-over-quarter from $3.8 million in Q3 2025.

Pluri (PLUR) Cash from Investing Activities (2010 - 2025) Analysis & Trends

Pluri (PLUR) has reported Cash from Investing Activities for 16 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash from Investing Activities fell 69.25% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $5.3 million (down 47.45% YoY), while the FY2025 annual figure was $8.0 million, down 24.17% from the prior year.
  • Cash from Investing Activities slipped to $2.7 million in Q4 2025 per PLUR's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $14.3 million in Q4 2021 and bottomed at -$23.8 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged $1.4 million across 5 years, with a median of $3.4 million in 2025.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 3635.31% — and 2025, when it surged 558.12%.
  • Pluri's Cash from Investing Activities stood at $14.3 million in 2021, then tumbled by 95.33% to $669000.0 in 2022, then jumped by 485.8% to $3.9 million in 2023, then jumped by 120.59% to $8.6 million in 2024, then plunged by 69.25% to $2.7 million in 2025.
  • Business Quant data shows PLUR's Cash from Investing Activities at $2.7 million in Q4 2025, $3.8 million in Q3 2025, and $3.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 2.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.66 Mn
Dec 31, 2025 2.66 Mn
Sep 30, 2025 3.85 Mn
Sep 30, 2025 3.85 Mn
Jun 30, 2025 3.03 Mn
Jun 30, 2025 3.03 Mn
Mar 31, 2025 -4.23 Mn
Mar 31, 2025 -4.23 Mn
Dec 31, 2024 8.65 Mn
Dec 31, 2024 8.65 Mn
Sep 30, 2024 585,000.00
Sep 30, 2024 585,000.00
Jun 30, 2024 -4.81 Mn
Jun 30, 2024 -4.81 Mn
Mar 31, 2024 5.67 Mn
Mar 31, 2024 5.67 Mn
Dec 31, 2023 3.92 Mn
Dec 31, 2023 3.92 Mn
Sep 30, 2023 5.80 Mn
Sep 30, 2023 5.80 Mn